Butterfly Medical announced today that it completed its Series C funding round, bringing in $21 million to support its BPH ...
Butterfly Medical, developer of a proprietary non-surgical solution for BPH (benign prostatic hyperplasia), today announced ...
An enlarged prostate is a big problem for men, no pun intended. According to Yale Medicine, about 50% of men between the ages of 51 and 60 have benign prostatic hyperplasia (BPH) or an enlarged ...
Medical Device Network on MSN
Butterfly Medical raises $21M in funds for BPH device development
The company has completed its pivotal clinical trial for the Butterfly prostatic retraction device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results